These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 19746839

  • 1. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
    Kim ST, Jang DJ, Kim JH, Park JY, Lim JS, Lee SY, Lee KM, Lim SJ, Kim CK.
    Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
    [Abstract] [Full Text] [Related]

  • 2. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
    Sandri G, Bonferoni MC, Gökçe EH, Ferrari F, Rossi S, Patrini M, Caramella C.
    J Microencapsul; 2010 Aug; 27(8):735-46. PubMed ID: 21034366
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
    Hu FQ, Wu MZh, Yuan H, Zhang HH.
    Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
    Yang ZQ, Xu J, Pan P, Zhang XN.
    Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.
    Puglia C, Blasi P, Rizza L, Schoubben A, Bonina F, Rossi C, Ricci M.
    Int J Pharm; 2008 Jun 05; 357(1-2):295-304. PubMed ID: 18343059
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.
    Bikkad ML, Nathani AH, Mandlik SK, Shrotriya SN, Ranpise NS.
    J Liposome Res; 2014 Jun 05; 24(2):113-23. PubMed ID: 24131382
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
    Souto EB, Wissing SA, Barbosa CM, Müller RH.
    Int J Pharm; 2004 Jun 18; 278(1):71-7. PubMed ID: 15158950
    [Abstract] [Full Text] [Related]

  • 20. RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia.
    Münster U, Nakamura C, Haberland A, Jores K, Mehnert W, Rummel S, Schaller M, Korting HC, Zouboulis ChC, Blume-Peytavi U, Schäfer-Korting M.
    Pharmazie; 2005 Jan 18; 60(1):8-12. PubMed ID: 15700772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.